Barings backs Inflexion's buyout of German medical consumables maker Primed
What's the deal? Barings has arranged secured credit facilities to support private equity firm InflexionDealroom has a profile for this one. Try Dealroom →'s investment in PrimedDealroom has a profile for this one. Try Dealroom → Group, a German manufacturer of medical consumables and sterilization services. Barings served as joint lead arranger; financial terms were not disclosed.
What does Primed do? Founded in 1946 and based in Halberstadt, Germany, Primed designs, manufactures, and distributes certified single-use medical products for hospitals and healthcare facilities. It employs more than 450 people across a vertically integrated platform spanning compounding to final sterile product delivery.
Its MDR-certified products reach more than 70 countries. The company also runs HA2Dealroom has a profile for this one. Try Dealroom →, which Barings describes as one of Europe's largest medical sterilization platforms.
Who's backing it? Inflexion, a European private equity firm, manages roughly €20 billion and targets middle-market businesses valued from €50 million to more than €1 billion. Barings, with about $502 billion in assets under management as of June 30, 2026, invests across credit, real assets, capital solutions, and emerging markets.
What's the endgame? The financing supports Inflexion and management as they look to expand Primed's medical technology platform.
Why now? "We are delighted to back Inflexion's acquisition of Primed, a prominent transaction in the Medtech sector in the DACH region," said Martin Siml, managing director at Barings Global Private Finance Group.
The signal: Debt financing from a large credit manager like Barings underscores continued lender appetite for private equity deals in defensive, regulated healthcare manufacturing across the DACH region.
Read more: pulse2.com
Image credit: Generated with Gemini
